Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Nuclear Medicine

  Free Subscription


Articles published in Brain

Retrieve available abstracts of 78 articles:
HTML format



Single Articles


    February 2025
  1. EIFF B, Bullmore ET, Clatworthy MR, Fryer TD, et al
    Extra-axial inflammatory signal and its relationship to peripheral and central immunity in depression.
    Brain. 2025;148:635-646.
    PubMed     Abstract available


  2. WARMENHOVEN N, Salvado G, Janelidze S, Mattsson-Carlgren N, et al
    A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests.
    Brain. 2025;148:416-431.
    PubMed     Abstract available


  3. MALPETTI M, Swann P, Tsvetanov KA, Chouliaras L, et al
    Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration.
    Brain. 2025;148:493-505.
    PubMed     Abstract available


    January 2025
  4. WIMBERLEY C, Thompson G
    Bridging peripheral and central inflammation with TSPO-PET: insights into depression and beyond.
    Brain. 2025 Jan 9:awae403. doi: 10.1093.
    PubMed    


    November 2024
  5. SAKATO Y, Shima A, Terada Y, Takeda K, et al
    Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson's disease.
    Brain. 2024;147:3702-3713.
    PubMed     Abstract available


  6. SPITZ G, Hicks AJ, McDonald SJ, Dore V, et al
    Plasma biomarkers in chronic single moderate-severe traumatic brain injury.
    Brain. 2024;147:3690-3701.
    PubMed     Abstract available


    October 2024
  7. BANWINKLER M, Dzialas V, Rigoux L, Asendorf AL, et al
    Putaminal dopamine modulates movement motivation in Parkinson's disease.
    Brain. 2024;147:3352-3357.
    PubMed     Abstract available


  8. D'ANGREMONT E, van der Zee S, Slingerland S, Slomp AC, et al
    Cholinergic deficiency in Parkinson's disease patients with visual hallucinations.
    Brain. 2024;147:3370-3378.
    PubMed     Abstract available


    September 2024
  9. ABANTO J, Dwivedi AK, Imbimbo BP, Espay AJ, et al
    Increases in amyloid-beta42 slow cognitive and clinical decline in Alzheimer's disease trials.
    Brain. 2024 Sep 11:awae216. doi: 10.1093.
    PubMed     Abstract available


    July 2024
  10. APPLETON J, Finn Q, Zanotti-Fregonara P, Yu M, et al
    Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer's disease.
    Brain. 2024 Jul 16:awae234. doi: 10.1093.
    PubMed     Abstract available


  11. DEVULDER A, Vanderlinden G, Van Langenhoven L, Testelmans D, et al
    Epileptic activity on foramen ovale electrodes is associated with sleep and tau pathology in Alzheimer's disease.
    Brain. 2024 Jul 11:awae231. doi: 10.1093.
    PubMed     Abstract available


  12. NILSSON J, Pichet Binette A, Palmqvist S, Brum WS, et al
    Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases.
    Brain. 2024;147:2414-2427.
    PubMed     Abstract available


    June 2024
  13. PERETTI DE, Boccalini C, Ribaldi F, Scheffler M, et al
    Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline.
    Brain. 2024 Jun 28:awae211. doi: 10.1093.
    PubMed     Abstract available


  14. ROEMER SN, Brendel M, Gnoerich J, Malpetti M, et al
    Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies.
    Brain. 2024 Jun 6:awae174. doi: 10.1093.
    PubMed     Abstract available


    May 2024
  15. ALTMANN A, Aksman LM, Oxtoby NP, Young A, et al
    Towards cascading genetic risk in Alzheimer's disease.
    Brain. 2024 May 31:awae176. doi: 10.1093.
    PubMed     Abstract available


  16. TETZLOFF KA, Martin PR, Duffy JR, Utianski RL, et al
    Longitudinal flortaucipir, metabolism and volume differ between phonetic and prosodic speech apraxia.
    Brain. 2024;147:1696-1709.
    PubMed     Abstract available


  17. CROWLEY SJ, Kanel P, Roytman S, Bohnen NI, et al
    Basal forebrain integrity, cholinergic innervation and cognition in idiopathic Parkinson's disease.
    Brain. 2024;147:1799-1808.
    PubMed     Abstract available


    April 2024
  18. CODY KA, Langhough RE, Zammit MD, Clark L, et al
    Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.
    Brain. 2024 Apr 26:awae116. doi: 10.1093.
    PubMed     Abstract available


  19. WANG YT, Therriault J, Servaes S, Tissot C, et al
    Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster tangle accumulation in females.
    Brain. 2024;147:1497-1510.
    PubMed     Abstract available


    March 2024
  20. DE MEYER S, Blujdea ER, Schaeverbeke J, Reinartz M, et al
    Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.
    Brain. 2024;147:936-948.
    PubMed     Abstract available


    February 2024
  21. YANG HS, Yau WW, Carlyle BC, Trombetta BA, et al
    Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
    Brain. 2024 Feb 5:awae034. doi: 10.1093.
    PubMed     Abstract available


    January 2024
  22. HERRANZ E, Treaba CA, Barletta VT, Mehndiratta A, et al
    Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
    Brain. 2024 Jan 30:awae030. doi: 10.1093.
    PubMed     Abstract available


  23. BAGNATO F, Sati P, Hemond CC, Elliott C, et al
    Imaging chronic active lesions in multiple sclerosis: a consensus statement.
    Brain. 2024 Jan 16:awae013. doi: 10.1093.
    PubMed     Abstract available


    December 2023
  24. SCHUMACHER J, Kanel P, Dyrba M, Storch A, et al
    Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.
    Brain. 2023;146:4964-4973.
    PubMed     Abstract available


    November 2023
  25. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Moscoso A, Scholl M, et al
    Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Brain. 2023;146:4520-4531.
    PubMed     Abstract available


    October 2023
  26. LAURENCIN C, Lancelot S, Brosse S, Merida I, et al
    Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study.
    Brain. 2023 Oct 3:awad338. doi: 10.1093.
    PubMed     Abstract available


    September 2023
  27. BOCANCEA DI, Svenningsson AL, van Loenhoud AC, Groot C, et al
    Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
    Brain. 2023;146:3719-3734.
    PubMed     Abstract available


  28. COOMANS EM, Tomassen J, Ossenkoppele R, Tijms BM, et al
    Genetically identical twin-pair difference models support the amyloid cascade hypothesis.
    Brain. 2023;146:3735-3746.
    PubMed     Abstract available


    August 2023
  29. KOSHIMORI Y, Cusimano MD, Vieira EL, Rusjan PM, et al
    Astrogliosis marker 11C-SL2511.88 PET in traumatic brain injury with persistent symptoms.
    Brain. 2023 Aug 21:awad279. doi: 10.1093.
    PubMed     Abstract available


  30. WUESTEFELD A, Pichet Binette A, Berron D, Spotorno N, et al
    Age-related and amyloid-beta-independent tau deposition and its downstream effects.
    Brain. 2023;146:3192-3205.
    PubMed     Abstract available


    July 2023
  31. AKSMAN LM, Oxtoby NP, Scelsi MA, Wijeratne PA, et al
    A data-driven study of Alzheimer's disease related amyloid and tau pathology progression.
    Brain. 2023 Jul 11:awad232. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  32. THERRIAULT J, Grothe MJ
    Towards in vivo PET imaging of primary age-related tauopathy.
    Brain. 2023 Jun 16:awad210. doi: 10.1093.
    PubMed    


  33. SCHOONHOVEN DN, Coomans EM, Millan AP, van Nifterick AM, et al
    Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET study.
    Brain. 2023 Jun 5:awad189. doi: 10.1093.
    PubMed     Abstract available


    April 2023
  34. NAM MH, Ko HY, Kim D, Lee S, et al
    Visualizing reactive astrocyte-neuron interaction in Alzheimer's disease using 11C-acetate and 18F-FDG.
    Brain. 2023 Apr 17:awad037. doi: 10.1093.
    PubMed     Abstract available


    February 2023
  35. JACK CR, Wiste HJ, Algeciras-Schimnich A, Figdore DJ, et al
    Predicting amyloid PET and tau PET stages with plasma biomarkers.
    Brain. 2023 Feb 15:awad042. doi: 10.1093.
    PubMed     Abstract available


  36. FLORIAN H, Wang D, Arnold SE, Boada M, et al
    Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study.
    Brain. 2023 Feb 2:awad024. doi: 10.1093.
    PubMed     Abstract available


    January 2023
  37. MENG Y, Goubran M, Rabin JS, McSweeney M, et al
    Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
    Brain. 2023 Jan 25:awac459. doi: 10.1093.
    PubMed     Abstract available


  38. VAN ARENDONK J, Neitzel J, Steketee RME, van Assema DME, et al
    Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study.
    Brain. 2023;146:337-348.
    PubMed     Abstract available


  39. KATSUMI Y, Putcha D, Eckbo R, Wong B, et al
    Anterior dorsal attention network tau drives visual attention deficits in posterior cortical atrophy.
    Brain. 2023;146:295-306.
    PubMed     Abstract available


    December 2022
  40. PERANI D
    The impact of integrated brain molecular PET measures on DLB cognitive phenotype and clinical course.
    Brain. 2022;145:4157-4159.
    PubMed    


  41. YOO HS, Jeong SH, Oh KT, Lee S, et al
    Interrelation of striatal dopamine, brain metabolism and cognition in dementia with Lewy bodies.
    Brain. 2022;145:4448-4458.
    PubMed     Abstract available


    November 2022
  42. TSAGKARIS S, Yau EKC, McClelland V, Papandreou A, et al
    Metabolic patterns in brain 18F-fluorodeoxyglucose PET relate to aetiology in paediatric dystonia.
    Brain. 2022 Nov 29:awac439. doi: 10.1093.
    PubMed     Abstract available


  43. VAN DER WEIJDEN CWJ, Biondetti E, Gutmann IW, Dijkstra H, et al
    Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status.
    Brain. 2022 Nov 21:awac436. doi: 10.1093.
    PubMed     Abstract available


  44. BETTHAUSER TJ, Bilgel M, Koscik RL, Jedynak BM, et al
    Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts.
    Brain. 2022;145:4065-4079.
    PubMed     Abstract available


    September 2022
  45. SPOTORNO N, Strandberg O, Vis G, Stomrud E, et al
    Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.
    Brain. 2022 Sep 21. pii: 6710203. doi: 10.1093.
    PubMed     Abstract available


  46. GROOT C, Smith R, Stomrud E, Binette AP, et al
    Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals.
    Brain. 2022 Sep 9. pii: 6695020. doi: 10.1093.
    PubMed     Abstract available


    August 2022
  47. INSEL PS, Young CB, Aisen PS, Johnson KA, et al
    Tau positron emission tomography in preclinical Alzheimer's disease.
    Brain. 2022 Aug 13. pii: 6665667. doi: 10.1093.
    PubMed     Abstract available


  48. LUO J, Agboola F, Grant E, Morris JC, et al
    Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan.
    Brain. 2022 Aug 4. pii: 6655799. doi: 10.1093.
    PubMed     Abstract available


    July 2022
  49. LONG JM, Coble DW, Xiong C, Schindler SE, et al
    Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.
    Brain. 2022 Jul 22. pii: 6648721. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  50. TANNER JA, Iaccarino L, Edwards L, Asken BM, et al
    Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
    Brain. 2022 Jun 28. pii: 6619120. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  51. ALSHELH Z, Brusaferri L, Saha A, Morrissey E, et al
    Neuroimmune signatures in chronic low back pain subtypes.
    Brain. 2022;145:1098-1110.
    PubMed     Abstract available


    February 2022
  52. ANG YS, Cusin C, Petibon Y, Dillon DG, et al
    A multi-pronged investigation of option generation using depression, PET and modafinil.
    Brain. 2022 Feb 12. pii: 6527662. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  53. WIESMAN AI, Murman DL, Losh RA, Schantell M, et al
    Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.
    Brain. 2022 Jan 28. pii: 6516524. doi: 10.1093.
    PubMed     Abstract available


  54. COOMANS EM, Tomassen J, Ossenkoppele R, Golla SSV, et al
    Genetically identical twins show comparable tau PET load and spatial distribution.
    Brain. 2022 Jan 12. pii: 6504924. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  55. REINARTZ M, Gabel S, Schaeverbeke J, Meersmans K, et al
    Changes in the language system as amyloid-beta accumulates.
    Brain. 2021;144:3756-3768.
    PubMed     Abstract available


  56. ABRAHAMSON EE, Kofler JK, Becker CR, Price JC, et al
    11C-PiB PET can underestimate brain amyloid-beta burden when cotton wool plaques are numerous.
    Brain. 2021 Dec 16. pii: 6464340. doi: 10.1093.
    PubMed     Abstract available


  57. TSAI HH, Chen YF, Yen RF, Lo YL, et al
    Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau.
    Brain. 2021;144:3371-3380.
    PubMed     Abstract available


  58. PASCOAL TA, Benedet AL, Tudorascu DL, Therriault J, et al
    Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Brain. 2021;144:3517-3528.
    PubMed     Abstract available


  59. HERMANIDES J, Hong YT, Trivedi M, Outtrim J, et al
    Metabolic derangements are associated with impaired glucose delivery following traumatic brain injury.
    Brain. 2021;144:3492-3504.
    PubMed     Abstract available


    November 2021
  60. YAN S, Zheng C, Paranjpe MD, Li Y, et al
    Sex modifies APOE epsilon4 dose effect on brain tau deposition in cognitively impaired individuals.
    Brain. 2021;144:3201-3211.
    PubMed     Abstract available


    October 2021
  61. DOPPLER CEJ, Kinnerup MB, Brune C, Farrher E, et al
    Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
    Brain. 2021;144:2732-2744.
    PubMed     Abstract available


  62. BERRON D, Vogel JW, Insel PS, Pereira JB, et al
    Early stages of tau pathology and its associations with functional connectivity, atrophy and memory.
    Brain. 2021;144:2771-2783.
    PubMed     Abstract available


  63. LEVY JP, Bezgin G, Savard M, Pascoal TA, et al
    18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Brain. 2021 Oct 19. pii: 6402002. doi: 10.1093.
    PubMed     Abstract available


  64. KHAN AF, Adewale Q, Baumeister TR, Carbonell F, et al
    Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380944. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  65. HOLLAND N, Malpetti M, Rittman T, Mak EE, et al
    Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
    Brain. 2021 Aug 16. pii: 6353021. doi: 10.1093.
    PubMed     Abstract available


  66. STROM A, Iaccarino L, Edwards L, Lesman-Segev OH, et al
    Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Brain. 2021 Aug 9. pii: 6346980. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  67. PEREIRA JB, Janelidze S, Smith R, Mattsson-Carlgren N, et al
    Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321226. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  68. WALSH J, Tozer DJ, Sari H, Hong YT, et al
    Microglial activation and blood-brain barrier permeability in cerebral small vessel disease.
    Brain. 2021;144:1361-1371.
    PubMed     Abstract available


  69. ZHOU L, Li G, Zhang Y, Zhang M, et al
    Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder.
    Brain. 2021;144:1488-1497.
    PubMed     Abstract available


  70. SCHUMACHER J, Gunter JL, Przybelski SA, Jones DT, et al
    Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Brain. 2021 Jun 11. pii: 6296589. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  71. HOSP JA, Dressing A, Blazhenets G, Bormann T, et al
    Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19.
    Brain. 2021;144:1263-1276.
    PubMed     Abstract available


    April 2021
  72. MAZERE J, Dilharreguy B, Catheline G, Vidailhet M, et al
    Striatal and cerebellar vesicular acetylcholine transporter expression is disrupted in human DYT1 dystonia.
    Brain. 2021;144:909-923.
    PubMed     Abstract available



  73. Corrigendum to: Monitoring the progression of Alzheimer's disease with tau-PET.
    Brain. 2021 Apr 6. pii: 6213355. doi: 10.1093.
    PubMed    


  74. PASCUAL B, Funk Q, Zanotti-Fregonara P, Cykowski MD, et al
    Neuroinflammation is highest in areas of disease progression in semantic dementia.
    Brain. 2021 Apr 6. pii: 6213358. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  75. EWERS M, Luan Y, Frontzkowski L, Neitzel J, et al
    Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6174116. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  76. ARNALDI D, Chincarini A, Hu MT, Sonka K, et al
    Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
    Brain. 2021;144:278-287.
    PubMed     Abstract available


    December 2020
  77. PEREIRA JB, Janelidze S, Ossenkoppele R, Kvartsberg H, et al
    Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer's disease.
    Brain. 2020 Dec 5. pii: 6024803. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  78. MOSCOSO A, Grothe MJ, Ashton NJ, Karikari TK, et al
    Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2020 Nov 30. pii: 6012955. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.